Evonik Venture Capital GmbH
Investor profile
Also recorded as: Evonik
Deals
12
distinct rounds
Companies
8
backed
Active span
2015–2024
10 yrs
Total round €
€190M
sum of rounds joined
Deals by year
distinct rounds / yearTop sectors
by dealsStages
by dealsCountries
by dealsCo-investment network
shared roundsHover a node for shared-deal counts; click a co-investor to open its profile.
Frequent co-investors
shared rounds- Chevron Technology Ventures3
- HydrogenOne Capital Growth PLC3
- Shell Ventures3
- Fountain Healthcare Partners2
- ING Corporate Investments2
- Panakès Partners2
- ABN AMRO1
- AP Ventures1
- BOLD1
- Clay Capital1
- DeepTech & Climate Fonds1
- Demcon Investment1
- Detlev Riesner1
- European Circular Bioeconomy Fund (ECBF)1
- Existing Shareholders1
- Formation 81
- High-Tech Gründerfonds1
- ICOS Capital Management1
- Investment Fund of Denmark (EIFO)1
- Jeremy Coller1
- Jürgen Schumacher1
- LIBERSET1
- Libertatis Ergo Holding of Leiden University1
- Life Sciences Partners1
- LSP1
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Strohm | Netherlands | 3 | €59M |
| Vivasure Medical | Ireland | 2 | €38M |
| Abolis Biotechnologies | France | 1 | €35M |
| In Ovo | Netherlands | 1 | €34M |
| HPNow | Denmark | 2 | €14M |
| Algal Scientific | UK | 1 | €6.4M |
| CASTOR | Israel | 1 | €3.0M |
| NumaFerm | Germany | 1 | €0 |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Abolis Biotechnologies | Other | €35M | 2024-09 |
| In Ovo | Series B | €34M | 2022-03 |
| Strohm | Other | €30M | 2024-07 |
| Vivasure Medical | Other | €22M | 2022-05 |
| Vivasure Medical | Series C | €16M | 2016-08 |
| Strohm | Other | €15M | 2022-12 |
| HPNow | Other | €14M | 2023-09 |
| Strohm | Other | €14M | 2022-08 |
| Algal Scientific | Series B | €6.4M | 2015-02 |
| CASTOR | Seed | €3.0M | 2021-08 |